Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 9.94
-0.5 %
$ 1.28 B
Market Cap
-16.03
P/E
NEO - STOCK-BASED COMPENSATION
Stock-based Compensation NEO - NeoGenomics, Inc.
33.4 M
LAST VALUE
16.37%
2 YEAR CAGR
27.29%
5 YEAR CAGR
47.36%
10 YEAR CAGR